25
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma: A Preliminary Report from a Randomized Multicenter Study

, , , , , , , , , , , & show all
Pages 101-105 | Accepted 28 Jun 1984, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Olusegun Osinbowale, Lobna Ali & Yung-Wei Chi. (2010) Venous Thromboembolism: A Clinical Review. Postgraduate Medicine 122:2, pages 54-65.
Read now
Ralph Benson & Beryl Hartley-Asp. (1990) Mechanisms of Action and Clinical Uses of Estramustine. Cancer Investigation 8:3-4, pages 375-380.
Read now

Articles from other publishers (21)

Kathleen Garland, Eric Mullins, Rachel S. Bercovitz, Vilmarie Rodriguez, Jean Connors & Nancy Sokkary. (2023) Hemostatic considerations for gender affirming care. Thrombosis Research 230, pages 126-132.
Crossref
Rami Alashram, Eneida Male & Parth Rali. 2020. Pulmonary Embolism. Pulmonary Embolism 1 12 .
Justine Defreyne, Laurens D L Van de Bruaene, Ernst Rietzschel, Judith Van Schuylenbergh & Guy G R T'Sjoen. (2019) Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons. Clinical Chemistry 65:1, pages 119-134.
Crossref
Kevin T. Nead, Ninjin Boldbaatar, David D. Yang, Sumi Sinha & Paul L. Nguyen. (2018) Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis. Urology 114, pages 155-162.
Crossref
Joseph J. Shatzel, Kara J. Connelly & Thomas G. DeLoughery. (2017) T hrombotic issues in transgender medicine: A review . American Journal of Hematology 92:2, pages 204-208.
Crossref
Ulrich R. Kleeberg. (2015) Kardiovaskuläre Risiken nach Androgen-Entzug. Info Onkologie 18:7, pages 26-26.
Crossref
Sean O'FarrellHans GarmoLars HolmbergJan AdolfssonPär StattinMieke Van Hemelrijck. (2015) Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer. Journal of Clinical Oncology 33:11, pages 1243-1251.
Crossref
Lasse J. Lapidus. 2013. Thromboembolism in Orthopedic Surgery. Thromboembolism in Orthopedic Surgery 19 33 .
P WongT Baglin. (2012) Epidemiology, risk factors and sequelae of venous thromboembolism. Phlebology: The Journal of Venous Disease 27:2_suppl, pages 2-11.
Crossref
Leonardo Tamariz, Thomas Harkins & Vinit Nair. (2012) A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiology and Drug Safety 21, pages 154-162.
Crossref
Andrew Connor, Craig Dick, James Bushnell & Jo Taylor. (2009) Do-It-Yourself Disaster. The American Journal of Medicine 122:5, pages 427-428.
Crossref
F. A. Anderson. (2003) Risk Factors for Venous Thromboembolism. Circulation 107:90231, pages 9I--16.
Crossref
Paul A. Komesaroff, Meryl Fullerton, Murray D. Esler, Garry Jennings & Krishnankutty Sudhir. (2002) Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer. Clinical Endocrinology 56:6, pages 745-753.
Crossref
Geoffrey H. Westrich & Adam J. Rana. (2001) Prevention and Treatment of Thromboembolic Disease: An Overview. Techniques in Orthopaedics 16:3, pages 279-290.
Crossref
C J Tyrrell. (1998) Controversies in the management of advanced prostate cancer. British Journal of Cancer 79:1, pages 146-155.
Crossref
Frederick A. AndersonJrJr & H. Brownell Wheeler. (1995) VENOUS THROMBOEMBOLISM. Clinics in Chest Medicine 16:2, pages 235-251.
Crossref
Rolf LundgrenOrjan NordleKenneth Josefsson. (1995) Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of Followup. Journal of Urology 153:5, pages 1580-1586.
Crossref
R. HAAPIAINEN, S. RANNIKKO, M. RUUTU, M. ALA-OPAS, E. HANSSON, H. JUUSELA, J. PERMI, M. SAARIALHO, J. VIITANEN & O. ALFTHAN. (1991) Orchiectomy versus Oestrogen in the Treatment of Advanced Prostatic Cancer. British Journal of Urology 67:2, pages 184-187.
Crossref
H. Becker, K.-H. Bichler, ST. H. Flüchter, U. W. Tunn, G. Ludwig, S. D. Fossa, H. Rübben, U. E. Studer, A. Putz, K. Bandhauer & E. Senn. 1991. Aktuelle Therapie des Prostatakarzinoms. Aktuelle Therapie des Prostatakarzinoms 251 358 .
P. Henriksson, M. Blombäck, G. Bratt, O. Edhag, A. Eriksson & O. Vesterqvist. (1989) Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Medical Oncology and Tumor Pharmacotherapy 6:3.
Crossref
Margareta Blombäck, Per Olov Hedlund & Urbain Säwe. (1988) Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. - predictors for cardiovascular complications?. Thrombosis Research 49:1, pages 111-121.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.